Cargando…

Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study

BACKGROUND: Intrahepatic cholestasis of pregnancy (ICP) is likely to lead to unfavorable consequences. Total bile acid (TBA) is thought to be the sole ICP indicator available as of now, but it comes with some kind of restrictions in terms of sensitivity and specificity. We were endeavoring to find p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lingyan, Li, Jingyang, You, Yilan, Qian, Zhiwen, Liu, Jiayu, Jiang, Ying, Gu, Ying, Xiao, Jianping, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661505/
https://www.ncbi.nlm.nih.gov/pubmed/38027820
http://dx.doi.org/10.1016/j.heliyon.2023.e21616
_version_ 1785137991688126464
author Chen, Lingyan
Li, Jingyang
You, Yilan
Qian, Zhiwen
Liu, Jiayu
Jiang, Ying
Gu, Ying
Xiao, Jianping
Zhang, Yan
author_facet Chen, Lingyan
Li, Jingyang
You, Yilan
Qian, Zhiwen
Liu, Jiayu
Jiang, Ying
Gu, Ying
Xiao, Jianping
Zhang, Yan
author_sort Chen, Lingyan
collection PubMed
description BACKGROUND: Intrahepatic cholestasis of pregnancy (ICP) is likely to lead to unfavorable consequences. Total bile acid (TBA) is thought to be the sole ICP indicator available as of now, but it comes with some kind of restrictions in terms of sensitivity and specificity. We were endeavoring to find potential diagnostic biomarkers for ICP in this investigation. METHODS: This case-control study with a prospective nature included 40 females in the stage of pregnancy who were diagnosed with ICP. It also included another 20 females who were also pregnant but with sound physical condition(control). Placental and plasma samples were collected from all females that were in the stage of pregnancy, except for 20 ICP patients, in which only plasma was collected. We used four-dimensional data-independent acquisition followed by enzyme-linked immunosorbent assay and immunohistochemistry to identify and validate plasma and placental profiles in ICP patients and controls. Bioinformatics was adopted in an effort to demonstrate the relevant biological processes and signalling pathways. Correlation analysis was used to analyse the consistency of tissue and plasma protein expression and the correlation between sequencing and experimental results. RESULTS: The expression levels of nectin-1 (NECTIN1), Kunitz-type protease inhibitor 1 (SPINT1), and inter-alpha-trypsin inhibitor heavy chain H3 (ITIH3) were remarkably higher in ICP patients than in controls. However, heparin cofactor 2 (SERPIND1) expression levels in female participants in the stage of pregnancy who were diagnosed with ICP were remarkably lower than those pregnant females with good physical fitness. In addition to the negative correlation between SERPIND1 and TBA, NECTIN1, SPINT1, and ITIH3 expression positively correlated with TBA. Area under the receiver operating characteristic curve (AUC) values of 0.7925, 0.8313, 0.8163, and 0.9025, respectively, were used to assess the diagnostic accuracies of NECTIN1, SPINT1, ITIH3, and SERPIND1. AUC (0.9438) was considerably greater when NECTIN1, SPINT1, and SERPIND1 were integrated, according to binary logistic regression. The AUC of the ROC curve for various combinations of SERPIND1 and other indicators was higher than itself, thus providing a more reliable ICP diagnosis. Furthermore, according to the bioinformatics analysis, the NECTIN1, SPINT1, ITIH3, and SERPIND1 were identified as secreted proteins because they were localized in the extracellular region. CONCLUSIONS: This research discovered new non-invasive ICP indicators. On top of this, it sheds new light on the crucial diagnostic function of secreted proteins in ICP.
format Online
Article
Text
id pubmed-10661505
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106615052023-11-08 Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study Chen, Lingyan Li, Jingyang You, Yilan Qian, Zhiwen Liu, Jiayu Jiang, Ying Gu, Ying Xiao, Jianping Zhang, Yan Heliyon Research Article BACKGROUND: Intrahepatic cholestasis of pregnancy (ICP) is likely to lead to unfavorable consequences. Total bile acid (TBA) is thought to be the sole ICP indicator available as of now, but it comes with some kind of restrictions in terms of sensitivity and specificity. We were endeavoring to find potential diagnostic biomarkers for ICP in this investigation. METHODS: This case-control study with a prospective nature included 40 females in the stage of pregnancy who were diagnosed with ICP. It also included another 20 females who were also pregnant but with sound physical condition(control). Placental and plasma samples were collected from all females that were in the stage of pregnancy, except for 20 ICP patients, in which only plasma was collected. We used four-dimensional data-independent acquisition followed by enzyme-linked immunosorbent assay and immunohistochemistry to identify and validate plasma and placental profiles in ICP patients and controls. Bioinformatics was adopted in an effort to demonstrate the relevant biological processes and signalling pathways. Correlation analysis was used to analyse the consistency of tissue and plasma protein expression and the correlation between sequencing and experimental results. RESULTS: The expression levels of nectin-1 (NECTIN1), Kunitz-type protease inhibitor 1 (SPINT1), and inter-alpha-trypsin inhibitor heavy chain H3 (ITIH3) were remarkably higher in ICP patients than in controls. However, heparin cofactor 2 (SERPIND1) expression levels in female participants in the stage of pregnancy who were diagnosed with ICP were remarkably lower than those pregnant females with good physical fitness. In addition to the negative correlation between SERPIND1 and TBA, NECTIN1, SPINT1, and ITIH3 expression positively correlated with TBA. Area under the receiver operating characteristic curve (AUC) values of 0.7925, 0.8313, 0.8163, and 0.9025, respectively, were used to assess the diagnostic accuracies of NECTIN1, SPINT1, ITIH3, and SERPIND1. AUC (0.9438) was considerably greater when NECTIN1, SPINT1, and SERPIND1 were integrated, according to binary logistic regression. The AUC of the ROC curve for various combinations of SERPIND1 and other indicators was higher than itself, thus providing a more reliable ICP diagnosis. Furthermore, according to the bioinformatics analysis, the NECTIN1, SPINT1, ITIH3, and SERPIND1 were identified as secreted proteins because they were localized in the extracellular region. CONCLUSIONS: This research discovered new non-invasive ICP indicators. On top of this, it sheds new light on the crucial diagnostic function of secreted proteins in ICP. Elsevier 2023-11-08 /pmc/articles/PMC10661505/ /pubmed/38027820 http://dx.doi.org/10.1016/j.heliyon.2023.e21616 Text en © 2023 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Chen, Lingyan
Li, Jingyang
You, Yilan
Qian, Zhiwen
Liu, Jiayu
Jiang, Ying
Gu, Ying
Xiao, Jianping
Zhang, Yan
Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study
title Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study
title_full Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study
title_fullStr Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study
title_full_unstemmed Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study
title_short Secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: A case-control study
title_sort secreted proteins in plasma and placenta as novel non-invasive biomarkers for intrahepatic cholestasis of pregnancy: a case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661505/
https://www.ncbi.nlm.nih.gov/pubmed/38027820
http://dx.doi.org/10.1016/j.heliyon.2023.e21616
work_keys_str_mv AT chenlingyan secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT lijingyang secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT youyilan secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT qianzhiwen secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT liujiayu secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT jiangying secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT guying secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT xiaojianping secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy
AT zhangyan secretedproteinsinplasmaandplacentaasnovelnoninvasivebiomarkersforintrahepaticcholestasisofpregnancyacasecontrolstudy